Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Allarity Therapeutics, Inc.
September 16, 2024 19:04 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Allarity Therapeutics, Inc. (ALLR) Misled Investors Regarding Dovitinib NDA’s Regulatory Prospects